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Background: People with eating disorders (ED) often report poor health-related quality of life (HRQoL), which is
explicitly correlated to illness’ severity and its effects on cognitive performance. We aimed to analyze health-related
quality of life (HRQoL) in subgroups of eating disorder (ED) patients by using the brief version of WHOQoL
questionnaire (WHOQoL-BREF) before treatment administration. Moreover, in order to compare our findings with
other published data, we carried out a comprehensive review of the literature on HRQoL in ED patients.
Methods: Our review was carried out by means of an accurate data mining of PsychInfo and Medline databases
and other available sources. In our cross-sectional study, eighty female ED patients (26 with bulimia nervosa, 33
with anorexia nervosa, 7 with binge eating disorder and 14 with ED not otherwise specified) completed the
WHOQoL-BREF. HRQoL scores were compared among ED subgroups and clinical information (presence of
previous contacts, length of illness, psychiatric comorbidity) was considered in the analysis.
Results: Our review shows that with few exceptions ED patients have a poorer HRQoL than the healthy population
of control and sometimes the mental component of HRQoL is the most involved dimension. Moreover, there are
no differences in the HRQoL among ED groups, even if AN patients in some studies have a lower HRQoL scores.
Furthermore, BED patients have a poorer HRQoL than obese patients who do not have binge episodes. Finally, all
treatments were positively correlated with an improvement on general and specific QoL dimensions. In our sample,
ED subgroups differed only for Psychological Health HRQoL scores (F = 4.072, df = 3; p = 0.01). No differences were
found between inpatients and outpatients, treatment naïve and previously treated patients and patients with or
without psychiatric comorbidity. Moreover, HRQoL scores were not correlated to length of illness within each
ED subgroup.
Conclusions: The analysis of the literature adds some relevant information on HRQoL in ED and may address
the future research toward the exploration of specific questions. One of these may be the prominent role of
Psychological Health domain in HRQoL, since our study confirms that this component is able to differentiate
eating disorders.
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According to the World Health Organization (WHO),
QoL refers to “the individuals’ perceptions of their pos-
ition in life in the context of the culture and value systems
in which they live and in relation to their goals, expecta-
tions, standards and concerns” [1]. On the other hand, the
concept of health-related QoL (HRQoL) encompasses
those aspects of overall quality of life that can be clearly
shown to affect health, either physical or mental. On the in-
dividual level, this includes physical and mental health per-
ceptions and their correlates, while on the community level
HRQoL includes resources, conditions, policies, and prac-
tices that influence a population’s health perceptions and
functional status [2]. As reviewed by Engel and colleagues
[3], most of studies investigating the HRQoL in eating
disorder (ED) patients measured the effects of abnormal
eating behavior on health status but not on HRQoL.
Specifically, the HRQoL is associated with the degree
of illness-related disability and effects of medical inter-
ventions on perceived HRQoL [4,5]. Indeed, people with
ED often report poor HRQoL [6], which is explicitly cor-
related to illness’ severity and its effects on cognitive per-
formance [7,8]. Cognitive impairments may significantly
reduce adherence to individualized rehabilitation pro-
grams, thus favoring chronicity and psychosocial deteri-
oration [9]. Moreover, ED are frequently associated with
comorbid psychiatric disorders, especially anxiety, soma-
toform and depressive disorders, which further prevent
recovery and increase the probability of resistance to
treatment efforts [10,11].
Hence, the assessment of HRQoL in ED is crucial to
predict the clinical outcome in patients undergoing
specific treatments, as well as the risk of relapse and re-
currence [12]. Although some ED-specific instruments
have been used to assess HRQoL [13], none of them
offers a global viewpoint of patient’s perception of HRQoL.
Conversely, the World Health Organization Quality of Life
(WHOQoL) questionnaire [1] measures patient’s subjective
awareness of illness related to physical and psychosocial
dysfunctioning.
We wanted to investigate HRQoL in eighty female ED
patients attending a Centre for Eating and Weight Disor-
ders in Italy. In order to place our results within the frame
of the current knowledge, we analyzed the literature and
realized that a comprehensive review on the factors that
can modulate HRQoL in eating disorders was lacking. So,
we decided to implement a review on this topic, by select-
ing published papers written in English. The aims of the
review were to:
 test the hypothesis that HRQoL is poorer in ED
subjects than in healthy individuals
 explore the existence of different levels of HRQoL
among different ED explore whether ED subjects have different
impairments on mental vs. physical dimension
of HRQoL
 explore the existence of differences in HRQoL
between obese subjects and subjects with BED
 analyze the efficiency of ED-specific HRQoL
instruments as compared with more general
instruments
 analyze the efficacy on HRQoL of the treatment
proposed for ED, including bariatric surgery.
Once that this review was completed, we were able to
compare the results obtained in our sample with those
emerging from all other studies. We were specifically
interested in analyzing the HRQoL among patients with
different eating disorders at the beginning of a psycho-
nutritional rehabilitation program and to explore whether
comorbid DSM-IV diagnoses, setting of care and history
of previous treatment were involved in their perception of
HRQoL.
Methods
Analysis of the literature
We firstly consulted other reviews on this topic, which
revealed a number of shortcomings. The review by Engel
et al. [3] is a narrative review focused only on the instru-
ments used to measure the HRQoL in ED patients. The
Authors identified four ED-specific HRQoL instruments
(the 25-item EDQOL, the 40-item EDQLS, the 55-item
HeRQUoLED and the 20-item QOL-ED) and discussed
their relevance in the field of the treatment of ED.
A second review was carried out by Passarelli-Tirico
et al. [14], who classified the papers according to the qual-
ity of the design, as defined by the Australian governative
Agency NHMRC. The shortcomings of this review are
that it is not in English and does not include the results of
HRQoL analyses.
The third review was carried out by Jenkins et al. using
a narrative approach [15]. This is a comprehensive review,
which allows to enter into the details of the papers and to
analyze specific issues such as the HRQoL associated with
subclinical ED pathology, BMI, or purging and other
compensatory behaviors. However, it does not include
a general table to compare the studies and does not at-
tempt to systematically describe the research design, the
setting or the type of assessment used.
In our comprehensive review we aimed to include
papers that used validated HRQoL instrument and to
classify patients according to definite diagnoses. Since
this was not always possible, we considered also papers
that assessed the patients according to eating dimensions
or to subclinical levels of disordered eating.
Accurate data mining was conducted by consulting
PsychInfo and Medline databases and other available
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reviewed. The databases were examined thoroughly using
the keywords “quality of life, QoL, HRQoL, functional
impairment, eating disorders, anorexia nervosa, bulimia
nervosa, binge eating disorder”.
The accuracy of the assessment among the papers
included was quite variable, ranging from simple ED
questionnaires to clinical or semi-structured interviews.
Most frequently, the assessment was conducted with in-
struments of the Eating Disorders Examination (EDE)
series, either questionnaire or interview. Other structured
instruments were the SCID or the PRIME-MD. In report-
ing the data means and SD where not shown, since these
statistics were not always inferable (for example, they were
shown in figures and not in tables) or else were too many
(one statistic for each ED and for each subscale) to be
included in the table. Moreover, apart from studies using
SF-36, most statistics were taken with miscellaneous
instruments and thus were not comparable.
Finally we excluded those papers that analyzed the
HRQoL in obese patients without attempting to assess
the presence of a whatsoever ED within the sample.
Procedures of the cross-sectional study
We recruited eighty female ED patients (mean age:
28.24 ± 11.28 SD; range: 13–61 years) attending the
Centre for Eating and Weight Disorders of the local
Socio-Health Unit (ASSL “Veneto Orientale”, Portogruaro,
Italy). This Center is a highly specialized unit, where
treatment-resistant ED subjects are referred from a vast
area including health districts both of Veneto and of Friuli
regions. On the other hand also subjects living in the
nearby surroundings can be accepted. Patients’ diagnoses
were established using the DSM-IV-TR criteria for An-
orexia Nervosa, Bulimia Nervosa, and Binge Eating Dis-
order. Subjects who did not meet full diagnostic criteria
were classified as Eating Disorder Not Otherwise Speci-
fied. Comorbidities were assessed taking in consideration
the medical history, and confirming their current presence
with the clinical assessment. Exclusion criteria included
the presence of clinically relevant multiorganic disorder or
cerebral organic impairment and patients not completing
the assessment for language barriers. All patients were
informed about the main objectives of our search and all
signed written informed consent.
Our study was carried out in compliance with the
Helsinki Declaration, using the database of Centre for
Weight and Eating Disorders of Portogruaro, a credited
agency of the Regional Health System. Patients gave
their written consent to the use of their data for both
clinical and research purposes at the time of their first
contact with the Centre. Since no new instrument or
investigation were used, a specific request to the local ethics
committee was not advanced, being valid the principle ofthe availability for research of the data gathered in the
clinical practice.
All participants were assessed for self-perception of
HRQoL using the WHOQoL-BREF [1] at the beginning
of treatment. This questionnaire is a 26-item short version
of the WHOQoL scale measuring the subjective percep-
tion of quality of life associated with physical and psy-
chological health, social performance and environment’s
characteristics. The Physical Health scale specifically in-
vestigates activity of daily living, dependence on drugs and
medical supports, level of energy, mobility, pain and dis-
comfort, sleep and rest, work capacity. The Psychological
Health scale explores body image and appearance, positive
and negative feelings, self-esteem, spirituality and personal
believes, cognitive functioning. The Social Relationship
scale measures quality of social relationships, social sup-
port and sexual activity. Finally, the Environment scale
evaluates individual’s socio-economic conditions (as finan-
cial resources, freedom, physical safety and security) and
the availability of facilities in living and working context
(accessibility to health and social care, home environment,
chances for acquiring new information and skills, re-
creation and leisure activities, physical environment
and transport).
Items are scored on a Likert five-point scale, were “1”
means severe discontent and “5” great approval; patients
had to evaluate their quality of life considering the two
weeks preceding the administration of the questionnaire.
The mean score of items within each scale was multi-
plied by 4 in order to be comparable to those of the
100-items WHOQOL scale.
Finally, height and weight were measured to calculate
the body mass index (BMI: kg/m2).
Statistical analysis
Data were analyzed using SPSS Version 16.0 for Windows
[16] and STATA 10.0 [17]. The statistical significance
(alpha) was set at p < 0.05. Firstly, data were inspected for
normality using the Shapiro-Wilk test.
Socio-demographic and clinical variables were com-
pared among ED subgroups using the Kruskal-Wallis or
Fisher’s exact test, as appropriate. Finally, an analysis of
covariance (multivariate ANCOVA) was used to examine
whether 1) there were significant differences between
ED subgroups, after controlling for age and length of
illness; 2) there were differences for HRQoL scores
between ED inpatients and outpatients, ED patients with
and without history of previous treatment, patients with
and without comorbid DSM-IV diagnosis, controlling for
ED diagnosis. Bonferroni’s correction for multiple com-
parisons was also applied.
Finally, Pearson’s correlation analysis was performed
to explore the relationship between HRQoL scores and
length of illness.
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As it shown in Table 1, three main typology of study
could be identified in the literature. The first one is the
population survey, carried out with different methods
and with dissimilar response rates. Some were postal
surveys, others were conducted via telephone, and further
more used a face to face interview. A second type of
design is the cross-sectional analysis of samples of subjects
attending outpatients ED centers or of patients waiting for
a gastric by-pass surgery. The third type of design is the
cohort prospective study. Within this category, there is
one single multi-wave survey and a number of papers
focused on treatments: within the latter studies, we can
enumerate RCT studies with drugs, one study with a spe-
cific psychotherapy (CBT) treatment, studies on patients
who attended a nutrition program or other unspecified
programs in ED centers and one study which evaluated a
gastric by-pass surgery intervention.
An important issue is the preference accorded from
most studies to the SF-36 scale or its derivatives for the
assessment of HRQoL. The SF-36 is a well-known but
unspecific instrument for the study of ED and allows a
distinction between mental component symptoms (MCS)
and physical component symptoms (PCS). Other generic
instruments include for example the WHO scale WHO-
BREF, which was used in a few studies. More specific
instruments are EDQoL, the HeRQUoLED, the EDQLS,
the IWQOL, but only few studies adopted them.
The main evidence that comes out from our review is
that with few exceptions ED patients have a poorer HRQoL
than the healthy population of control. Frequently MCS is
the most involved dimension, which means that ED pa-
tients are particularly vulnerable to impairment in the QoL
because of their psychic difficulties, being the physical
component less harming. But this is not always the rule.
Another piece of evidence is that frequently there are
no differences in the HRQoL among ED groups. AN
patients in some studies have a lower HRQoL and this is
particularly evident when a specific instrument is used,
like the EDQoL.
Among potential surgical patients waiting for a GBP,
most - but not all - studies conclude that BED patients
have a poorer HRQoL than obese patients who do not
have binge episodes.
Finally, when we consider the efficacy of the treatment
on HRQoL measures, all treatments were positively cor-
related with an improvement on the general and, when
examined, specific QoL dimensions. However, when com-
pared with healthy individuals, their HRQoL remained
still below the norm.
Characteristics of our sample
All relevant socio-demographic and clinical data of our
cross-sectional study are reported on Tables 2 and 3.Fifty-nine out of 80 subjects were outpatients (73.8%)
whereas the remaining 21 (26.3%) were inpatients. Among
all patients, 33 (41.3%) were affected by AN (mean age:
26.1 years ±10.6 SD), 26 (32.5%) were affected by BN
(mean age: 27.5 years ±8.0 SD), 7 were diagnosed as BED
subjects (8.8%) (mean age: 41.6 years ± 14.0 SD) and
14 patients suffered from EDNOS (17.5%) (mean age:
28.1 years ± 13.3 SD). In addition, 14 patients (11 in-
patients and 3 outpatients) fulfilled DSM-IV criteria for
other ED: two for Borderline Personality Disorder (2.5%),
nine for Major Depressive Disorder (11.3%) and one each
for Bipolar Disorder, Alcohol Abuse and Social Phobia.
Forty-six patients had a history of previous therapies
for ED (25 inpatients and 21 outpatients) whereas the
remaining 34 subjects were all treatment-naïve ED
inpatients.
ED subgroups significantly differed for age (χ2 = 8.293,
p = 0.040), BMI (χ2 = 54.916; p < 0.001), age at onset
(χ2=; p = 0.02), age at first evaluation (χ2 = 8.198; p = 0.04)
and length of illness (χ2 = 9.585; p = 0.022). Also, differ-
ences among ED subgroups were found for marital status
(p < 0.001), setting (p = 0.005), history of previous treat-
ments (p < 0.001) but not for educational level or living
conditions, occupational status, proportion of patients
completing their studies and DSM-IV psychiatric disorder
comorbidity (p > 0.05).
Significant differences emerged when considering the
presence of a history of previous treatments for ED, both
between ED inpatients (100% untreated) and outpatients
(54.3% untreated) (p < 0.001) and between patients with
psychiatric comorbidity (14.2% untreated) and without
psychiatric comorbidity (48.5% untreated) (p = 0.03). In
opposition, no difference was detected for psychiatric co-
morbidity between inpatients (81% no comorbidity) and
outpatients (85.7% no comorbidity) (p > 0.05).
HRQoL scores in our sample
All ED patients’ HRQoL scores were below normative
population values (Table 4). Results of ANCOVA showed
that ED subgroups differed only for Psychological Health
QoL scores (F = 4.072, d.f. = 3; p = 0.01; ANCOVA, age and
length of illness as covariates). No differences were found
for all HRQoL scores when patients were subgrouped for
BMI levels (underweight: < 18.5 BMI; normal weight:
18.5-24 BMI; overweight/obese: ≥ 25) (p > 0.05, ANOVA
or Kruskal-Wallis test, as appropriate). As to respect to ill-
ness’ awareness, differences among ED subgroups did not
reach statistical significance (p > 0.05, Fisher’s exact test).
No differences for HRQoL scores were found between
inpatients and outpatients, as well as treatment naïve or
previously treated patients (p > 0.05). Also, ED patients
with a DSM-IV comorbid diagnosis did not differ from
those without psychiatric comorbidity for HRQoL scores
(p > 0.05; ANCOVA, ED diagnosis as covariate). Ultimately,
Table 1 Review of the literature on QoL in eating disorders subjects
Study Design, treatment Setting, characteristics
of whole sample




Results on general and specific









PRIME-MD SF-20 • BED (as well other MD) < No-MD.
• BED < non-BED on social
functioning and bodily pain
[18] Hay 2003 Comunity survey 3010 out of 4400
(response rate 70%)















(54 BN, 22 BED, 7 AN)
1148 non-ED subjects Ad-hoc questionnaire
based on DSM-IV
SF-36 • ED < non-ED subj on MCS,
but not on PCS.





Community survey 1895 adolescents 400 ED not classified
according DSM criteria
1495 non-ED SCOFF, not confirmed
by interview
KINDL-R • ED < non-ED
[21] Vallance
et al., 2011




2+ episodes of binge
eating per month
109 women with <2
episodes of binge
eating per month






324 interviewed at the
second stage





EDE-Q + EDE SF- 12,
WHOQOL-
BREF
• ED < Healthy women on MCS
[23] Mitchison
et al., 2013
Population survey 3034 out of 5000 selected
(response rate 60.7%)
89 AN (2.9% of
respondents)




SF-36 • AN < other subj on most
domains, including MCS.
• Subj with history of AN < other
subj on MCS but not on PCS.
• Impairment on social functioning







Cross-sectional study ED outpatient center 126 ED (52 AN, 74 BN) 98 males with angina;
122 hearth transplant
candidates; 54 cystic
fibrosis pts; 91 students
Clinical interview
(DSM-III-R)
NHP • Specific differences between ED
and pts with organic diseases
[10] Padierna
et al., 2000
Cross-sectional study ED outpatient center 197 ED (116 AN,






SF-36 • ED pts < normative population.


















Table 1 Review of the literature on QoL in eating disorders subjects (Continued)
[25] Gonzalez-
Pinto et al., 2004
Cross-sectional study ED outpatient center 47 AN No control SCID I and II SF-36 • Predictive variables for PCS: poor
outcome in previous year,
comorbidity and female gender.
• For MCS: comorbidity and
purging behaviors







156 ED pts (44 AN, 43
BN, 69 EDNOS) and
148 former ED pts
Dutch normative
population and 591
Mood Disorders (MD) pts
DSM-IV diagnosis
based on EDE-Q +
BMI and menstrual
status
SF-36 • No diff among ED groups.
• ED < normative.





Pts referred to ED
treatment program
87 ED pts (34 AN,







• ED pts < normative subjects.
• Restricting AN pts > other
patient groups.








155 ED, 56 diet/exercise Validation across groups,
including 327 non-ED subj




• All EDQOL subscale scores
differed between groups, with
greater impairment in ED pts.
• EDQOL more sensitive than
SF-36 when predicting group
status (ED vs. diet/exercise)







146 ED pts (44 AN,
43 BN, 59 EDNOS)
146 former ED DSM-IV diagnosis
based on EDE-Q +
BMI and menstrual
status
SEIQOL • ED with poor QoL on all
life domains.
• Former ED pts > ED pts on






ED outpatient center 11 AN, 5 BN, 3 BED,
30 EDNOS, 4 non-ED
New Zealand normative
population
EDE-Q SF-36 ED < normative on MCS.
• QoL general and PCS predicted





ED outpatient center 156 ED (80 AN,
40 BN, 36 EDNOS)
Comparison across
ED groups







ED center (in- and
out-patients)
80 ED (26 BN; 33 AN;







• No diff among ED groups.














78 obese surgical pts 78 obese (9 BED)
after GBP surgery
110 preoperative
control group (19 BED)
Phone interview +
MFED + QWEPR
SF-36 • Postoperative pts >
preoperative pts.
• Postoperative pts < US





Pts undergoing a medical
school based ED treatment
94 BED US normative population
and Obeses without
binges (n = 312)
Clinical interview
(DSM-IV)
SF-36 • BED < normative.






















530 obese candidates to
residential modification
program
95 BED 435 non-BED Questionnaire on
Eating/Weight Patterns; BDI;
SC90-R








56 BED 62 non-BED EDE, PRIME-MD IWQOL-Lite • BED < non-BED on total scale,




Cross-sectional study 180 bariatric surgery
candidates, 93 participants
to a weight loss support
group, 158 community
respondents
38 BED, 46 subj with
feelings of loss of
control (LOC) during
binge episodes




SF-36 • BED < non-BED on MCS
[36] Folope
et al., 2012
Cross-sectional study 130 obese in clinical
nutrition center
73 ED 57 non-ED SCOFF-F + BULIT,
not confirmed by
a diagnosis









123 non-binge eaters EDE IWQOL-A • Binge eating < no-binge eating.










2223 ED 7465 non-ED Ad-hoc questionnaire,
EDE-Q, not confirmed
by interview









SF-36 • Improvement in PCS and social
function, followed by MCS.
• Scores after 2 years still below
normative population.






358 subj in treatment
programs in Health centers








• ED < general population.
• After 1 year PCS improved
but not MCS.






3 and 6 months
follow-ups) to validate
EDQLS
ED treatment programs 130 ED pts (56 AN,
39 BN, 35 EDNOS)
QoL measures at






• EDQLS total scores increased
at 3 and 6 months.
• EDQLS responsiveness exceeded






























Interview, BES, EDE SF-36 • Treated subjects improved in QoL,
with improvement larger in BED,





(10 weeks RCT with
topiramate)
60 BN women recruited
through advertisements
30 BN on topiramate 30 BN on placebo SCID-I and SCD-II SF-36 • Topiramate improved QOL to a










152 BED on Placebo EDE IWQOL-Lite • Sibutramine efficaciuos on








In-patient in ED center 206 ED pts (71 AN,
55 BN, 80 EDNOS)
35 subj without diagnosis Clinical interview EEE-C
QOLscores,
SF12
• QoL improved during inpatient
treatment and between admission
and 12 months after discharge.
• AN, BN and EDNOS < no diagnosis.
• Specific differences among ED





ED residential center 65 AN (33 high
Readiness for
Change - RFC - females





SF-36 v2 • Participants’ QoL below US average.
• 81% discharged below the US
average.





Cohort study 65 surgical (GBP) pts 33 BED 32 non-BED ED-SCID, QWEP-R SF-36 • QoL improved from
pre-surgery to post-surgery.
• BED < non-BED on social
functioning at pre-surgery
and after 6 months postsurgery
Glossary of QoL instruments.
AQoL, assessment of quality of life.
EDE-Q, eating disorder examination questionnaire.
EDQLS, eating disorders quality of life.
EEE-C QOL, eating and exercise examination QOL.
HeRQoLED, health related quality of life for the eating disorders.
IWQOL, impact of weight on quality of life-lite.
Kindl-R: Revised German-language questionnaire to assess Health-Related Quality of Life in children and adolescents.
NHP, Nottingham health profile questionnaire.
QOLOD, quality of life, obesity and dietetics rating scale.
SEIQOL, schedule for the evaluation of individual quality of life.
SF-36, short form (36) health survey.

















Table 2 Socio-demographic and clinical characteristics of ED patients: continuous variables
AN (N = 33) BN (N = 26) BED (N = 7) EDNOS (N = 14) Kruskal-Wallis test Significance
Age (years) 26.09 ± 10.59 27.46 ± 7.96 41.57 ± 14.01 28.07 ± 13.28 χ2 = 8.293 p = 0.040
BMI (kg/m2) 15.97 ± 1.88 21.99 ± 5.17 32.40 ± 8.26 24.73 ± 7.29 χ2 = 54.916 p < 0.001
Age at onset (years) 19.21 ± 6.93 17.92 ± 5.37 36.14 ± 15.40 22.57 ± 13.20 χ2 = 9.585 p = 0.022
Age at first evaluation (years) 26.06 ± 10.61 27.39 ± 8.00 41.57 ± 14.01 28.07 ± 13.28 χ2 = 8.198 p = 0.040
Lenght of illness (years) 6.88 ± 7.27 9.54 ± 7.20 5.43 ± 7.00 5.50 ± 9.97 χ2 = 9.456 p = 0.020
Mean ± SD.
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of illness within each ED subgroup (p > 0.05, Pearson’s
correlation analysis).
Discussion
The main evidences coming out from our review are the
followings:Table 3 Socio-demographic and clinical characteristics of ED pa
AN (N = 33) BN (N = 26)
Occupation
Yes 7 (21.2%) 13 (50%)
No 26 (78.8%) 13 (50%)
Marital status
Unmarried 29 (87.9%) 21 (80.7%)
Married or coupled 3 (9.1%) 2 (7.7%)
Divorced or separated 1 (3.0%) 3 (11.5%)
Educational level
Primary school 16 (48.5%) 5 (19.2%)
High school 11 (33.3%) 17 (65.4%)
University 6 (18.2%) 4 (15.4%)
Living conditions
Alone 3 (9.1%) 2 (7.7%)
With others 30 (90.9%) 24 (92.3)
Patients completing education
Yes 14 (42.4%) 8 (30.8%)
No 19 (57.6%) 18 (69.2%)
Setting
Inpatients 14 (42.4%) 7 (26.9%)
Outpatients 19 (57.6%) 19 (73.1%)
Previous treatment for ED
Yes 27 (81.8%) 14 (53.8%)
No 6 (18.2%) 12 (46.1%)
DSM-IV comorbidity
Yes 7 (21.2%) 6 (23.1%)
No 26 (78.8%) 20 (76.9%)
Illness’ awareness
Yes 21 (63.6%) 16 (61.5%)
No 12 (36.4%) 10 (38.5%) the surveys confirmed that ED patients have a
poorer HRQoL than the general population and this
is evident in particular when considering the mental
component of the quality of life;
 among the obese patients, quite invariably the BED
had a poorer HRQoL than non-BED subjects. This
is an important piece of information, since ittients: categorical variables
BED (N = 7) EDNOS (N = 14) Fisher’s exact test
P = 0.070
4 (57.1%) 7 (50%)
3 (42.9%) 7 (50%)
P < 0.001
1 (14.3%) 11 (78.6%)
5 (71.4%) 3 (21.4%)
1 (14.3%) 0
P = 0.093
5 (71.4%) 6 (42.9%)




7 (100%) 13 (92.9%)
P = 0.810
2 (28.6%) 5 (35.7%)
5 (71.4%) 9 (64.3%)
P = 0.005
0 0
7 (100%) 14 (100%)
P < 0.001
1 (14.3%) 4 (28.6%)
6 (85.7%) 10 (71.4%)
P = 0.431
0 0
7 (100%) 14 (100%)
P = 0.548
5 (71.4%) 6 (42.9%)
2 (28.6%) 8 (57.1%)
Table 4 HRQoL scores among ED subgroups
HRQoL domains ED diagnosis Mean SD Statistics Significance
Physical
AN 12.69 ± 3.09
F = 0.638 p = 0.593
BN 12.39 ± 3.40
BED 11.75 ± 2.21
EDNOS 13.59 ± 3.55
Psychological
AN 11.28 ± 1.28
F = 4.390 p = 0.007^
BN 11.04 ± 1.45
BED 10.52 ± 0.94
EDNOS 12.56 ± 1.96
Social
AN 10.87 ± 3.86
F = 0.772 p = 0.513
BN 10.76 ± 3.01
BED 11.43 ± 4.21
EDNOS 12.47 ± 4.10
Environment
AN 12.35 ± 2.55
F = 0.383 p = 0.766
BN 12.80 ± 2.09
BED 13.14 ± 3.36
EDNOS 12.96 ± 2.02
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http://www.biomedcentral.com/1471-244X/14/165supports the idea that there is a need of specific
treatments for BED, which are not simply an
adaptation of general nutrition intervention;
 in the cohort studies, we can distinguish general
programs aimed to treat the ED from specific
psychotherapies and RCT with psychotropic drugs.
Even if the published data seem to reassure that
many treatments are able to improve the HRQoL,
we remain with the doubt whether the amelioration
was due to some specific characteristics of the
treatment or was a generic result of the caring of
these patients. Much has to be done in order to
respond to the question “what aspect of treatment
improve HRQoL of ED patients?”.
Furthermore, we must highlight the fact that most
studies used general scales for measuring the HRQoL,
and in particular the SF-36. Since much fewer infor-
mation comes from studies that used specific scales
(such as EDQOL), so far it is not possible to draw
conclusion on the advantages of the latter scales. On
the other hand, the analysis of Table 1 may suggest
that the use of ED specific scales is able to increase
the probability to discover subtle differences in HRQoL
among different ED groups or between pre- and post-
treatment scores.
When we consider our cross-sectional study, we must
admit that our sample is of relatively small size, even if
it is on average with other studies. To overcome this
limit we used a non-parametric test (Kruskall-Wallis
test), which in principle does not put limits in the
sample size.The main difference of our research as compared with
other studies is that we included both inpatients and
outpatients. It is worth noting that over 40% of outpa-
tients, but none of the inpatients, had a history of previ-
ous treatments. If we assume that inpatients have a
more severe illness, we may speculate that these patients
did not seek help because of their low illness’ awareness
and, in addition, that primary care physicians did not
identify an ED in these subjects, although they were pre-
senting important weight alterations, repetitive vomiting
or bingeing [48]. Therefore, specific interventions were
dramatically delayed until the need for an admission was
necessary.
Additionally, over 85% of patients with comorbid psy-
chiatric diagnoses reported a history of previous treat-
ment for ED, in comparison to 50% of patients without
coexisting psychiatric diagnoses. These results may indi-
cate that the presence of comorbidity increased the
probability to be treated earlier. We know from previous
surveys that ED are frequently comorbid with Major
Depressive Disorder, Anxiety Disorders and Substance
or Alcohol Abuse [49] and also that ED relapses and
successive hospitalizations reduce the response to treat-
ment of comorbidity [50,51]. We may conclude that the
comorbidity of severe ED psychopathology with other
psychiatric disorders contributed to chronicity of illness
and should be considered as a prognostic factor influen-
cing long-term outcomes of rehabilitation programs and
increasing financial dependence on society [52-54].
As far as HRQoL is concerned, our study confirmed
results obtained by previous investigations, demonstrating
that ED patients experienced reduced HRQoL. Surprisingly,
Baiano et al. BMC Psychiatry 2014, 14:165 Page 11 of 12
http://www.biomedcentral.com/1471-244X/14/165ED inpatients and outpatients did not differ as for HRQoL
scores. Most ED inpatients in our sample were AN, thus
confirming that anorexic behaviors implicate a high risk of
organic complications and require a large amount of in-
tensive medical care [55]. It is possible that AN inpatients
did not report greater limitations of QoL in comparison to
the other subgroups, because of a poor perception of
psychosomatic distress [56,57]. Moreover, we found no
differences in HRQoL between ED patients with and with-
out a comorbid DSM-IV diagnosis, as well as between
patients with and without a history of previous treatments.
Furthermore, HRQoL scores were not significantly
correlated to length of illness within each ED sub-
group. Taken together, all these negative results may
indicate that our patients were impaired in their quality of
life independently from their history and current severity
of illness.Conclusions
Finally, when we consider the specific domains of HRQoL
involved, the only difference among the ED groups was
present in the Psychological component, where patients
with EDNOS reported the highest HRQoL scores and pa-
tients with BED the lowest ones. In fact EDNOS patients
represent a heterogeneous category of subjects with eating
behaviors generating a relatively modest distress [58,59],
and our EDNOS patients seem to confirm this rule. Also
the data on our patients with BED are in agreement with
previous studies, which documented great health dissa-
tisfaction, increased risk of main medical disorders [60],
difficulties in regulating emotions [61] and concurrence of
personality traits, as well as comorbidity with mood and
anxiety disorders [62,63] in binge eaters. All together,
these last results may indicate the need in the future
studies to focus the attention in particular on the charac-
teristics of the psychological domain of HRQoL in eating
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